Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00485225 · ClinicalTrials.gov registry record · Phase 2
Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain
A Phase 2 study, sponsored by Durect.
- Completed
- Registry status
- Phase 2
- Development phase
- 77
- Enrollment target
NCT00485225 is a Phase 2 study that has completed, run by Durect. The registered enrollment target is 77 participants.
The verdict
NCT00485225, a Phase 2 study, has completed, sponsored by Durect.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 77 participants
- Enrollment target
Study Summary
Two stage study looking at different titration schedules in patients with moderate to severe non-malignant chronic pain. Up to 80 patients at approximately 15 centers in the US to be enrolled. Study participation is approximately 3 months.
Interventions
- DRUG EN3270
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2007-06 |
| Est. Completion | 2008-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00485225
The ClinicalTrials.gov registry entry for NCT00485225 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Durect, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EN3270 is the first listed.
NCT00485225 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00485225 about?
NCT00485225 is a clinical study titled "Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain". Two stage study looking at different titration schedules in patients with moderate to severe non-malignant chronic pain. Up to 80 patients at approximately 15 centers in the US to be enrolled. Study participation is approximately 3 months.
What is the current status of trial NCT00485225?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 77 participants. The study started on 2007-06. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00485225?
The interventions under investigation include: EN3270 (DRUG).
Who is sponsoring clinical trial NCT00485225?
This trial is sponsored by Durect, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.